Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial

Chemotherapy is not effective for hepatocellular carcinoma (HCC). HMG-CoA redutase inhibitors have cytostatic activity for cancer cells, but their clinical usefulness is unknown. To investigate whether pravastatin, a potent HMG-CoA reductase inhibitor, prolongs survival in patients with advanced HCC...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kawata, S, Yamasaki, E, Nagase, T, Inui, Y, Ito, N, Matsuda, Y, Inada, M, Tamura, S, Noda, S, Imai, Y, Matsuzawa, Y
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2001
Assuntos:
Regular Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2363838/
https://ncbi.nlm.nih.gov/pubmed/11286466
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1716
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados